Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease

M Masutani1, H Nakagama, T Sugimura

  • 1Biochemistry Division, National Cancer Center Research Institute, 1-1 Tsukiji 5-chome, Tokyo 104-0045, Japan. mmasutan@gan2.res.ncc.go.jp

Insights

Poly(ADP-ribose) polymerase (PARP)-1 deficiency causes DNA repair issues and genomic instability, impacting cancer and autoimmune disease development. Stronger PARP inhibitors may improve cancer therapy and treat autoimmune conditions.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Carcinogenesis involves complex genetic alterations.
  • Poly(ADP-ribose) polymerase (PARP)-1 deficiency is linked to DNA repair defects, genomic instability, and altered gene transcription.
  • PARP-1 plays a role in tumor cell growth and is implicated in neoplasms and cancer risk.

Purpose of the Study:

  • To investigate the role of PARP-1 and related enzymes in carcinogenesis and autoimmune diseases.
  • To explore the therapeutic potential of PARP inhibitors in cancer and autoimmune conditions.

Main Methods:

  • Genetic analyses of the PARP-1 gene in neoplasms.
  • Investigating the impact of poly(ADP-ribose) and its metabolism using PARG inhibitors and deficient animals.
  • Examining the association of PARP-1 genetic variations with cancer risk and autoimmune disease susceptibility.

Main Results:

  • PARP-1 deficiency leads to DNA repair defects, genomic instability, and affects cell death and gene transcription.
  • Alterations in the PARP-1 gene, including mutations and polymorphisms, are found in various cancers.
  • PARP-1 genetic variations are associated with increased risk for prostate cancer and rheumatoid arthritis.

Conclusions:

  • Further research on PARP-1, PARG, and other PARP family members is crucial for understanding cancer and autoimmune disease pathogenesis.
  • Development of potent PARP inhibitors holds promise for enhancing chemo- and radiation therapy efficacy in cancer and treating autoimmune diseases.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...